الفهرس 
Maternal and neonatal tetanusOnly 14 pages are availabe for public view
 |  | from | 133 |  |  |
| | | from | 133 | | |
Abstract
Background: Tetanus is an acute fatal disease characterized by generalized rigidity and convulsive spasms of skeletal muscles. There is no natural immunity against tetanus; protection can be provided by active immunization with tetanus toxoid vaccine or administration of an anti-tetanus antibody. Maintaining maternal and neonatal elimination status in Egypt will require continued strengthening of routine tetanus toxoid immunization services that target pregnant women, routine immunization of children, clean delivery services in all districts and to identify the main reasons for bad performance.
Objective:To measure frequency rate of tetanus toxoid vaccination among women attending well baby clinic to vaccinate their infants or to follow up at El-Darb El-Ahmar PHC center at Cairo governorate and to identify different associated factors affecting this rate.
Subjects and methods: This study was a cross sectional study targeting (277) mothers at childbearing period attending the well baby clinic at El-Darb El-Ahmar PHC center. Mothers were interviewed to answer a questionnaire which included the socio-demographiccharacteristics of the woman, obstetric history, details of the last pregnancy and knowledge about maternal and neonatal tetanus disease.
Results: The results indicated that more than sixty percent of the studied mothers (60.6%) were vaccinated with at least one dose of tetanus toxoid vaccination and only (42.6%) of the studied mothers were fully protected against maternal and neonatal tetanus at their last birth.
Factors found to be associated with the rate of vaccination were: socioeconomic level, educational level, place of receiving ANC, receiving HE about TT vaccine, knowledge of women about NT disease and TT vaccine and the source of this knowledge.
Conclusion: The percentage of protection at last birth against MNT is low among women at child bearing period and certain interventions should be taken toward the modified factors to increase the tetanus toxoid coverage.